180 related articles for article (PubMed ID: 31885745)
1. High Lipoprotein(a) Level Is Independently Associated with Adverse Clinicopathological Features in Patients with Prostate Cancer.
Wang FM; Zhang Y
Dis Markers; 2019; 2019():9483935. PubMed ID: 31885745
[TBL] [Abstract][Full Text] [Related]
2. The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study.
Ioannidou A; Watts EL; Perez-Cornago A; Platz EA; Mills IG; Key TJ; Travis RC; ; Tsilidis KK; Zuber V
PLoS Med; 2022 Jan; 19(1):e1003859. PubMed ID: 35085228
[TBL] [Abstract][Full Text] [Related]
3. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.
Wettstein MS; Saba K; Umbehr MH; Murtola TJ; Fankhauser CD; Adank JP; Hofmann M; Sulser T; Hermanns T; Moch H; Wild P; Poyet C
Prostate; 2017 Apr; 77(5):549-556. PubMed ID: 28093792
[TBL] [Abstract][Full Text] [Related]
5. Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.
Salgado-Montilla J; Soto Salgado M; Surillo Trautmann B; Sánchez-Ortiz R; Irizarry-Ramírez M
Lipids Health Dis; 2015 Sep; 14():111. PubMed ID: 26377420
[TBL] [Abstract][Full Text] [Related]
6. A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screening.
Randazzo M; Beatrice J; Huber A; Grobholz R; Manka L; Chun FK; Recker F; Kwiatkowski M
Eur Urol; 2015 Oct; 68(4):591-7. PubMed ID: 24794075
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk.
Zhang JQ; Geng H; Ma M; Nan XY; Sheng BW
Med Sci Monit; 2015 Aug; 21():2387-96. PubMed ID: 26275075
[TBL] [Abstract][Full Text] [Related]
8. [Changes of blood lipids in colorectal cancer patients with coronary heart disease and value of lipid-lowering therapy with statins].
Liang ZT; Wang XP; Zeng QT; Liao YH; Gao CY; Li MW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):863-5. PubMed ID: 18504222
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Prostate Cancer by Opportunistic Screening in Korean Men with a Prostate-Specific Antigen Level Less Than 4.0 ng per Milliliter.
Choi H; Cho S; Bae JH; Lee SE; Hong SK; Moon DG; Cheon J; Byun SS; Park JY
Urol Int; 2017; 99(2):143-148. PubMed ID: 28395285
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.
Shen Y; Chen S; Dai Y; Wang XQ; Zhang RY; Yang ZK; Hu J; Lu L; Ding FH; Shen WF
Cardiovasc Diabetol; 2019 Jun; 18(1):82. PubMed ID: 31234867
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.
Carlsson S; Maschino A; Schröder F; Bangma C; Steyerberg EW; van der Kwast T; van Leenders G; Vickers A; Lilja H; Roobol MJ
Eur Urol; 2013 Nov; 64(5):693-9. PubMed ID: 23683475
[TBL] [Abstract][Full Text] [Related]
12. Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy.
Sun X; Liu Z; Yang Z; Xiao L; Wang F; He Y; Su P; Wang J; Jing B
Diagn Pathol; 2013 Dec; 8():208. PubMed ID: 24350576
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
[TBL] [Abstract][Full Text] [Related]
15. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.
Murtola TJ; Kasurinen TVJ; Talala K; Taari K; Tammela TLJ; Auvinen A
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):66-76. PubMed ID: 30214034
[TBL] [Abstract][Full Text] [Related]
16. Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism.
Konerman M; Kulkarni K; Toth PP; Jones SR
J Clin Lipidol; 2012; 6(1):27-32. PubMed ID: 22264571
[TBL] [Abstract][Full Text] [Related]
17. Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels.
Cai G; Huang Z; Zhang B; Yu L; Li L
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30894407
[TBL] [Abstract][Full Text] [Related]
18. Low-Density Lipoprotein Cholesterol and Prostate Cancer: A Retrospective Study.
Hu P; Cheng R; Chen G; Hu X; Shen Y
Arch Esp Urol; 2024 Apr; 77(3):229-234. PubMed ID: 38715162
[TBL] [Abstract][Full Text] [Related]
19. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease.
Frohlich J; Dobiásová M; Adler L; Francis M
Physiol Res; 2004; 53(5):481-6. PubMed ID: 15479125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
